Brady Stein
Distinguished in Philadelphia-Negative Chronic Myeloid Leukemia

Dr. Brady Stein

Hematology
Northwestern Medical Group
233 E Superior St 1st Fl, Olson Pavilion, 
Chicago, IL 
Offers Telehealth

Distinguished in Philadelphia-Negative Chronic Myeloid Leukemia
Northwestern Medical Group
233 E Superior St 1st Fl, Olson Pavilion, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Brady Stein is a Hematologist in Chicago, Illinois. Dr. Stein is rated as a Distinguished provider by MediFind in the treatment of Philadelphia-Negative Chronic Myeloid Leukemia. His top areas of expertise are Polycythemia Vera, Myelofibrosis, Myeloproliferative Neoplasms (MPN), and Essential Thrombocythemia.

His clinical research consists of co-authoring 83 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Philadelphia-Negative Chronic Myeloid Leukemia.

Graduate Institution
Emory University School Of Medicine
Specialties
Hematology
Licenses
Internal Medicine in MD
Board Certifications
American Board Of Internal Medicine - Hematology (Certified)
Fellowships
Johns Hopkins University
Hospital Affiliations
Northwestern Memorial Hospital
Northwestern Lake Forest Hospital
Northwestern Medicine Central Dupage Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 13 Less Insurance Carriers -

Locations

233 E Superior St 1st Fl, Olson Pavilion, Chicago, IL 60611
Call: 866-587-4322

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

A Phase 3, Randomized, Double-blind, Active-Control Study of Pelabresib (CPI-0610) and Ruxolitinib vs. Placebo and Ruxolitinib in JAKi Treatment Naive MF Patients
A Phase 3, Randomized, Double-blind, Active-Control Study of Pelabresib (CPI-0610) and Ruxolitinib vs. Placebo and Ruxolitinib in JAKi Treatment Naive MF Patients
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2025
Intervention Type: Drug
Study Drugs: CPI-0610 BET Small Molecule Inhibitor, Ruxolitinib
Study Phase: Phase 3
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy - The C-TRACT Trial
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy - The C-TRACT Trial
Enrollment Status: Active_not_recruiting
Publish Date: December 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Phase 1/2 Study of CPI-0610, a Small Molecule Inhibitor of BET Proteins: Phase 1 (Dose Escalation of CPI-0610 in Patients With Hematological Malignancies) and Phase 2 (Dose Expansion of CPI-0610 With and Without Ruxolitinib in Patients With Myeloproliferative Neoplasms)
A Phase 1/2 Study of CPI-0610, a Small Molecule Inhibitor of BET Proteins: Phase 1 (Dose Escalation of CPI-0610 in Patients With Hematological Malignancies) and Phase 2 (Dose Expansion of CPI-0610 With and Without Ruxolitinib in Patients With Myeloproliferative Neoplasms)
Enrollment Status: Completed
Publish Date: October 08, 2025
Intervention Type: Drug
Study Drugs: CPI-0610, Rituximab
Study Phase: Phase 1/Phase 2
A Multicenter, Open-Label, Pilot Study of Alisertib (MLN8237), a Novel Inhibitor of Aurora Kinase A, in Adult Patients With Relapsed/Refractory Acute Megakaryoblastic Leukemia or Myelofibrosis (Including Primary and Post-Essential/Post-Polycythemic Myelofibrosis)
A Multicenter, Open-Label, Pilot Study of Alisertib (MLN8237), a Novel Inhibitor of Aurora Kinase A, in Adult Patients With Relapsed/Refractory Acute Megakaryoblastic Leukemia or Myelofibrosis (Including Primary and Post-Essential/Post-Polycythemic Myelofibrosis)
Enrollment Status: Unknown
Publish Date: May 26, 2021
Intervention Type: Drug, Other
Study Phase: Not Applicable
A Phase 1, Single Arm, Single Center Pilot Study of Medi4736, an Anti-Pdl1 Therapy, for Patients With Myelofibrosis
A Phase 1, Single Arm, Single Center Pilot Study of Medi4736, an Anti-Pdl1 Therapy, for Patients With Myelofibrosis
Enrollment Status: Withdrawn
Publish Date: August 20, 2019
Intervention Type: Biological, Other
Study Phase: Phase 1
View 4 Less Clinical Trials

83 Total Publications

Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL.
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL.
Journal: Blood
Published: March 09, 2023
View All 83 Publications
Similar Doctors
Distinguished in Philadelphia-Negative Chronic Myeloid Leukemia
Dr. Jessica K. Altman
Hematology | Oncology
Distinguished in Philadelphia-Negative Chronic Myeloid Leukemia
Dr. Jessica K. Altman
Hematology | Oncology
675 N St Clair St Ste 21-100, Galter Pavilion, 
Chicago, IL 
 (0.1 miles away)
866-587-4322
Experience:
25+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jessica Altman is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Altman has been practicing medicine for over 25 years and is rated as an Elite provider by MediFind in the treatment of Philadelphia-Negative Chronic Myeloid Leukemia. Her top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Distinguished in Philadelphia-Negative Chronic Myeloid Leukemia
Dr. Parameswaren Venugopal
Hematology | Oncology
Distinguished in Philadelphia-Negative Chronic Myeloid Leukemia
Dr. Parameswaren Venugopal
Hematology | Oncology

Rush University Medical Group

1620 W Harrison St, 
Chicago, IL 
 (3.2 miles away)
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Parameswaren Venugopal is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Venugopal is rated as a Distinguished provider by MediFind in the treatment of Philadelphia-Negative Chronic Myeloid Leukemia. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Venugopal is currently accepting new patients.

Distinguished in Philadelphia-Negative Chronic Myeloid Leukemia
Dr. Juehua Gao
Hematology
Distinguished in Philadelphia-Negative Chronic Myeloid Leukemia
Dr. Juehua Gao
Hematology
251 E Huron St Ste 7-209A, Feinberg Pavilion, 
Chicago, IL 
 (0.1 miles away)
312-926-9319
Experience:
28+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Juehua Gao is a Hematologist in Chicago, Illinois. Dr. Gao has been practicing medicine for over 28 years and is rated as a Distinguished provider by MediFind in the treatment of Philadelphia-Negative Chronic Myeloid Leukemia. Her top areas of expertise are Acute Myeloid Leukemia (AML), Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), and Acute Myeloblastic Leukemia without Maturation.

VIEW MORE PHILADELPHIA-NEGATIVE CHRONIC MYELOID LEUKEMIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Stein's expertise for a condition
ConditionClose
  • Elite
  • Essential Thrombocythemia
    Dr. Stein is
    Elite
    . Learn about Essential Thrombocythemia.
    See more Essential Thrombocythemia experts
  • Myelofibrosis
    Dr. Stein is
    Elite
    . Learn about Myelofibrosis.
    See more Myelofibrosis experts
  • Myeloproliferative Neoplasms (MPN)
    Dr. Stein is
    Elite
    . Learn about Myeloproliferative Neoplasms (MPN).
    See more Myeloproliferative Neoplasms (MPN) experts
  • Polycythemia Vera
    Dr. Stein is
    Elite
    . Learn about Polycythemia Vera.
    See more Polycythemia Vera experts
  • Distinguished
  • Adult Immune Thrombocytopenia
    Dr. Stein is
    Distinguished
    . Learn about Adult Immune Thrombocytopenia.
    See more Adult Immune Thrombocytopenia experts
  • Chronic Myelogenous Leukemia (CML)
    Dr. Stein is
    Distinguished
    . Learn about Chronic Myelogenous Leukemia (CML).
    See more Chronic Myelogenous Leukemia (CML) experts
  • Hemangioma Thrombocytopenia Syndrome
    Dr. Stein is
    Distinguished
    . Learn about Hemangioma Thrombocytopenia Syndrome.
    See more Hemangioma Thrombocytopenia Syndrome experts
  • Immune Thrombocytopenic Purpura (ITP)
    Dr. Stein is
    Distinguished
    . Learn about Immune Thrombocytopenic Purpura (ITP).
    See more Immune Thrombocytopenic Purpura (ITP) experts
  • Philadelphia-Negative Chronic Myeloid Leukemia
    Dr. Stein is
    Distinguished
    . Learn about Philadelphia-Negative Chronic Myeloid Leukemia.
    See more Philadelphia-Negative Chronic Myeloid Leukemia experts
  • Shwartzman Phenomenon
    Dr. Stein is
    Distinguished
    . Learn about Shwartzman Phenomenon.
    See more Shwartzman Phenomenon experts
View All 8 Distinguished Conditions
  • Advanced
  • Anemia
    Dr. Stein is
    Advanced
    . Learn about Anemia.
    See more Anemia experts
  • Antiphospholipid Syndrome
    Dr. Stein is
    Advanced
    . Learn about Antiphospholipid Syndrome.
    See more Antiphospholipid Syndrome experts
  • Autoimmune Hemolytic Anemia
    Dr. Stein is
    Advanced
    . Learn about Autoimmune Hemolytic Anemia.
    See more Autoimmune Hemolytic Anemia experts
  • Blood Clots
    Dr. Stein is
    Advanced
    . Learn about Blood Clots.
    See more Blood Clots experts
  • Budd-Chiari Syndrome
    Dr. Stein is
    Advanced
    . Learn about Budd-Chiari Syndrome.
    See more Budd-Chiari Syndrome experts
  • Deep Vein Thrombosis
    Dr. Stein is
    Advanced
    . Learn about Deep Vein Thrombosis.
    See more Deep Vein Thrombosis experts
View All 13 Advanced Conditions
  • Experienced
  • Acute Eosinophilic Pneumonia
    Dr. Stein is
    Experienced
    . Learn about Acute Eosinophilic Pneumonia.
    See more Acute Eosinophilic Pneumonia experts
  • Acute Myeloid Leukemia (AML)
    Dr. Stein is
    Experienced
    . Learn about Acute Myeloid Leukemia (AML).
    See more Acute Myeloid Leukemia (AML) experts
  • Agranulocytosis
    Dr. Stein is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • ALK-Positive Non-Small Cell Lung Cancer
    Dr. Stein is
    Experienced
    . Learn about ALK-Positive Non-Small Cell Lung Cancer.
    See more ALK-Positive Non-Small Cell Lung Cancer experts
  • Ataxia-Pancytopenia Syndrome
    Dr. Stein is
    Experienced
    . Learn about Ataxia-Pancytopenia Syndrome.
    See more Ataxia-Pancytopenia Syndrome experts
  • Beta Thalassemia
    Dr. Stein is
    Experienced
    . Learn about Beta Thalassemia.
    See more Beta Thalassemia experts
View All 28 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.